A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis‐Targeting Chimeras Enhanced Immunotherapy
Yaping Wu(Shanghai Jiao Tong University), Shuyang Sun(Shanghai Jiao Tong University)
Cited by 107
Related Papers
Clinical utility of PDX cohorts to reveal biomarkers of intrinsic resistance and clonal architecture changes underlying acquired resistance to cetuximab in HNSCC
|Signal Transduction and Targeted Therapy|2022|37